Anti-IgE and anti-fcεRI autoantibodies in clinical allergy

Current Opinion in Immunology

Volumn 8, Issue 6, 1996, Pages 784-789

  Fiebiger, Edda ^a   Stingl, Georg ^a   Maurer, Dieter ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN E ANTIBODY;

ALLERGIC REACTION; ATOPY; BASOPHIL; CHRONIC URTICARIA; HUMAN; MAST CELL; SHORT SURVEY;

EID: 0030471440     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80005-7     Document Type: Article

References (40)

1. Avrameas S: Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton' Immunol Today 1991, 12:154-159.
2. Coutinho A, Kazatchkine MD, Avrameas S: Natural autoantibodies. Curr Opin Immunol 1995, 7:812-818.
3. Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW: Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993, 328:1599-1604.
4. Fiebiger E, Maurer D, Holub H, Reininger B, Hartmann G, Woisatschläger M, Kinet J-P, Stingl G: Serum IgG autoantibodies directed against the α chain of FcεRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995, 96:2606-2612. In this study, the occurrence of IgE-independent IgG autoreactivity directed against racombinant and cell-surface-expressed FcεRIα was demonstrated in various biochemical detection systems. In contrast to anti-IgE autoAbs, anti-FcεRIα autoAbs ware observed selectively in sera from CU patients but from neither atopic patients nor healthy control individuals.
5. Stadler BM: Biological activities of anti-IgE antibodies. Int Arch Allergy Immunol 1993, 102:121-126.
6. Williams RC, Griffiths RW, Emmons JD, Field RC: Naturally occurring human antiglobullns with specificity for gamma-E. J Clin Invest 1972, 51:955-963.
7. Paganelli R, Quinti I. Carbonari M, Pomtesilli O, D'Offizi GP, Letta T, Aiuti F: IgG anti-IgE in circulating immune complexes in the hyper IgE syndrome. Clin Allergy 1986, 16:513-521.
8. Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP: Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988, 90:213-217
9. Marone G, Casaralo V, Paganelli R, Quinti I: IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J Invest Dermatol 1989, 93:246-252.
10. Grattan CEH, Francis DM, Hide M, Greaves MW; Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991, 21:695-704.
11. Inganas M, Jonansson SGO, Bennich H: Anti-IgE antibodies in human serum: occurrence and specificity, Int Arch Allergy Appl Immunol 1981, 65:51-61.
12. Miescher S, Vogel M, Stämpfli MR, Wasserbauer E, Kricek F, Vorburger S, Stadler BM: Domain-specific anti-IgE antibodies interfere with IgE binding to FcsRII. Int Arch Allergy Immunol 1994. 105:75-62.
13. Stadler BM, Rudolf MP, Zürcher AW, Miescher S, Vogel M: Anti-IgE in allergic sensitization. Immunol Cell Biol 1996, 74:195-200.
14. Czech W, Stadler BM, Schöpf E, Kapp A: IgE autoantibodies in atopic dermatitis-occurrence of different antibodies against the CH3 and the CH4 epitopes of IgE Allergy 1995, 50:243-246.
15. Davis FM, Gossett LA, Pinkston KL, Liou RS, Sun LK, Kim YW, Chang NT, Chang TW, Wagner K, Bews J et al.: Can anti-IgE be used to treat allergy? Springer Semin immunopathol 1993, 15:51-73.
16. Tsumjimura K, Park YH, Mijama-Inaba M, Meguro T Orino T, Ueda M, Masuda T: Comparative studies on FcR (FcRII. FcRIII, and FcR alpha) functions of murine B cells. J Immunol 1990, 144:4571-4578.
17. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV: A 13-amino-acid motif in the cytoplasmic domain of FcyRIIB modulates B-cell receptor signaling. Nature 1994, 368:70-73.
18. Ashman RF, Peckham D, Stunz LL: Fc receptor off-signal in the B cell involves apoptosis. J Immunol 1996, 157:5-11.
19. Hebert J, Bemier D, Mourad W: Detection of auto-anti-idiotypic antibodies to Lot p 1 (rey 1) IgE antibodies in human sera by the use of murine idiotypes: levels in atopic and non-atopic subjects and effects of immunotherapy. Clin Exp Immunol 1990, 80:413-419.
20. Valacer DJ, O'Reilly ME, Illowite NT, Bonagura VR: Identification of anti-idiotyplc antibodies in the sera of ryegrass-allergic and nonallergic individuals. J Allergy Clin Immunol 1991, 88:349-355.
21. Nagpal S, Shanthi KN, Kori R, Schröder H, Metcalfe DD, Rao PVS: Induction of allergen-specific IgE and IgG responses by anti-idiotypic antibodies. J Immunol 1989, 142:3411-3415.
22. Vogel M, Miescher S, Biaggi C, Stadler BM: Human anti-IgE antibodies by repertoire cloning. Eur J Immunol 1994, 24:1200-1207.
23. Ritter C, Baltig M, Krämer R, Stadler BM: IgE hidden in immune complexes with anti-IgE autoantibodies in children with asthma. J Allergy Clin Immunol 1991, 88:793-601.
24. Stämpfli MR, Rudolf M, Miescher S, Pachlopnik JM, Stadler BM: Antigen-specific inhibition of IgE binding to the high-affinity receptor. J Immunol 1995, 155:2948-2954.
25. Daeron M, Malbec O, Latour S, Arock M, Fridman WH: Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995, 95:577-585. Cross-linking of FcεRI on the surface of MCs and basophils leads to the release of inflammatory mediators. In vitro, this phenomenon can be inhibited by cross-linking FcεRI to the tyrosine-based inhibitory motif-containing Isoform of FcγyRII (FcγyRIIB).
26. Bieber T, De-la-Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, Hanau D, De-la-Salle C: Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FcεRI). J Exp Med 1992, 175:1285-1290.
27. Wang B, Rieger A, Kilgus O. Ochiai K, Maurer D, Fodinger D, Kinet J-P, Stingl G: Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcεRI, J Exp Med 1992, 175:1353-1365.
28. 2 but lack the FcεRIβ-chain at both the protein and the RNA level. This newly defined FcεRI complex is functional, as demonstrated by its capacity to mediate IgE-dependant antigen presentation.
29. Kaplan AP: Chronic urticaria: possible causes, suggested treatment alternatives. Postgrad Med 1983, 74:209-215, 218-222.
30. Champion RH: A practical approach to urticarial syndromes- a dermatologist's view. Clin Exp Allergy 1990, 20:221-224.
31. Gratlan CEH, Boon AP, Eady RAJ, Winkelrnann RK: The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 1990, 93:158-204.
32. Niimi N, Francis DM, Kermani F, O'Donnell BF, Hide M, KobazaBlack A, Winkelrnann RK, Greaves MW, Barr RM: Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996, 106:1001-1006
33. Kermani F, Niimi N, Francis DM, O'Donnell B, Black AK, Hafizi S, Yacoub M, Greaves MW: Characterization of a novel mast cell-specific histamine releasing activity in chronic idiopathic urticaria [abstract]. J Invest Dermatol 1995, 105:452.
34. Donald SMM, Rafnar T, Langdon J, Lichtenstein LM: Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995, 269:688-690.
35. Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin M-H, Kilgus O, Kinet J-P, Stingl G: Expression of functional high affinity immunoglobulin E receptors (FcεRI) on monocytes of atopic individuals. J Exp Med 1994, 179:745-750.
36. Gounni AS, Lamkhioued B. Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet J-P, Capron M: High affinity IgE receptor on eoslnophils is involved In defense against parasites. Nature 1994, 367:183-186.
37. Grattan CEH, Francis DM, Slater NGP, Barlow RJ, Greaves MW: Plasmapheresis for severe, unremitting, chronic urticarla, Lancet 1992, 339:1078-1080.
38. Saban R, Haak-Frendscho M, Zine M, Ridgway J, Gorman C, Presta L, Bjorling D, Saban M, Jardieu P: Human FcεRI-IgG and humanized anti-IgE monoclonal antibody MaE11 block passive sensitlzation of human and rhesus monkey lungs. J Allergy Clin Immunol 1994, 94:836-843.
39. Naito K, Hirama M, Oku mura K, Ra C: Soluble form of the human high-affinity receptor for IgE Inhibits recurrent allergic reaction a novel mouse model of type I allergy. Eur J Immunol 1995, 25:1631-1637.
40. Wiegand TW, Williams PB, Dreskir SC, Jouvin M-H, Kiret J-P, Tassel D: High-affinity ollgonucleotide ligands to human IgE inhibit binding to Fee receptor I. J Immunol 1996, 157:221-230.